Gainers
Genprex, Inc. (NASDAQ: GNPX) shares surged 167.2% to settle at $3.50 on Monday. The FDA granted Fast Track Designation for Genprex’s lead drug candidate, Reqorsa Immunogene combination therapy.
Gainers
Everspin Technologies, Inc. (NASDAQ: MRAM) shares surged 63.2% to close at $10.74 on Friday after the company reported better-than-expected Q3 results and issued Q4 sales guidance above estimates.
Upgrades
For Bouygues (OTC:BOUYF), Jefferies upgraded the previous rating of Hold to Buy. At the moment, the stock has a 52-week-high of $43.06 and a 52-week-low of $33.96. Bouygues closed at $42.20 at the end of the last trading period.